NervGen Pharma Corp. Opens the Market
May 02 2019 - 10:59AM
PR Newswire (Canada)
TORONTO, May 2, 2019 /CNW/ - Bill
Radvak, Executive Chairman, NervGen Pharma Corp. (NGEN),
joined Tim Babcock, Managing
Director, Capital Formation, TSX Venture Exchange, to open the
market. NervGen is a regenerative medicine company dedicated to the
advancement of innovative therapeutics for the treatment of nerve
damage, including spinal cord injuries and peripheral nerve
injuries. NervGen Pharma Corp. commenced trading on TSX Venture
Exchange on March 13, 2019.
SOURCE TMX Group Limited
Copyright 2019 Canada NewsWire
Nervgen Pharma (TSXV:NGEN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Nervgen Pharma (TSXV:NGEN)
Historical Stock Chart
From Oct 2023 to Oct 2024